The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study to evaluate the safety and efficacy of immunotherapy with tremelimumab and durvalumab in multiple myeloma patients receiving high dose chemotherapy and autologous stem cell transplant (HDT/ASCT) + peripheral blood lymphocyte (PBL) reinfusion.
 
Alexander M. Lesokhin
Honoraria - Bristol-Myers Squibb; Gilead Sciences (I); Janssen Oncology; Novartis
Consulting or Advisory Role - Aduro Biotech; Bristol-Myers Squibb; Foundation Medicine (Inst); Janssen Oncology; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Serametrix (Inst)
Patents, Royalties, Other Intellectual Property - Serametrix, Inc
 
David J. Chung
No Relationships to Disclose
 
Hearn J. Cho
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech; Janssen Research & Development
Research Funding - Agenus; Bristol-Myers Squibb; Janssen Research & Development
 
Lisa Shohara
Employment - Aptiv Solutions; ICON Clinical Research
 
Paul Schwarzenberger
No Relationships to Disclose
 
Toni Ricciardi
Employment - Cascade Medical Enterprises
Stock and Other Ownership Interests - Becton Dickinson; Cascade Medical Enterprises
Consulting or Advisory Role - Cascade Medical Enterprises
 
Mary J. Macri
Employment - Eisai
Stock and Other Ownership Interests - Pfizer
 
Aileen Ryan
Stock and Other Ownership Interests - Amgen; Immunogen; Teva
 
Ralph Rudolph Venhaus
Stock and Other Ownership Interests - Dynavax Technologies; Soligenix